FDA can and should use its authority and discretion under the Food, Drug & Cosmetic Act to allow CBD to be marketed with necessary regulations and restrictions, CRN said.
The campaign has pulled in just over half of the global GDP, and a quarter of global CO2 emissions, represented by cities, regions, companies, and investors.
While the dietary supplement industry continues to adapt, here's a look at how protocol may be changing for manufacturing, research, marketing and more.
Following a challenge from Procter & Gamble, which has a competing dietary supplement, GSK maintains that its product is “100% natural,” and “clinically proven to curb cravings.”
The California-based supplement manufacturer published this free manual to provide the industry with a foundational guide to compliance with FDA standards.
Both the Council for Responsible Nutrition and the BBB’s National Advertising Division are optimistic about the industry’s ongoing self-regulatory efforts.
The company is sounding the alarm after allegedly encountering multiple doctored versions of lab reports by product marketers and ingredients suppliers.
Abnormal weather patterns sullied fishing off Peru's north-central coast early this year, and COVID-19 concerns will hamper operations to a certain extent.
During the height of the COVID-19 pandemic, Americans for Free Trade believes more must be done to alleviate the burden of tariffs on overseas imports.
Purveyors of dietary supplements, IV 'therapies,' and ozone 'therapies' were accused by the FTC of purporting that their products could fight COVID-19.
The mushroom-based ingredient can make licensed support claims on immune function, bone health, and general well-being in both adults and children in the Canadian marketplace.
Due to COVID-19, FDA announced that it will begin conducting its inspection activities electronically for the remainder of the public health emergency.
Sales of cannabidiol-based products have soared during the past year, and now formulators are rolling out CBD products designed to ease a variety of ailments.
A flood of all types of consumer products in the marketplace warrants a review of available scientific evidence.
By Marilyn Barrett, PhD, Pharmacognosy Consulting, Inc., Mary Ellen Cosenza, PhD, MEC Regulatory & Toxicology Consulting, Steven Dentali, PhD, Dentali Botanical Sciences, and Sandy Bigelow, PhD, Vanguard Global Associates LLC04.02.20